drugset / Trial / NCT02337569

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency

NCT02337569

Phase 3 Completed 57 enrolled Nobelpharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate efficacy and safety of NPC-02 in patients with Zinc Deficiency.

Timeline

Start
2015-01
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown Oral